Aziminezhadan Parisa, Pouramini Alireza, Ghassemof Hesam, Hosseinzadeh Fereshteh, Hosseinzadeh Fatemeh, Seyedipour Sina, Abbasi Danial, Sheikhbahaei Erfan
Aziminezhadan Breast Clinic, Tehran, Iran.
Kerman Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.
Ultrasound. 2025 Feb 28:1742271X241305025. doi: 10.1177/1742271X241305025.
A large percentage of women fear benign breast lesion surgery, and it is a burden to the healthcare system. Ultrasound-guided vacuum-assisted excision (VAE) is as effective as surgery but does not require general anaesthesia, leaves no scars, and improves patient satisfaction.
A retrospective analysis of a prospective cohort research carried out on recorded data of a single breast surgeon. VAE was performed on 611 patients with ACR BIRADS 3 or 4a lesions utilising EnCor Enspire equipment and a 7G probe. The average follow-up time was 30.25 ± 9.12 months.
A total of 772 VAEs were performed on lesions with an average diameter of 18.81 ± 8.63 mm. Pathology results revealed fibroadenoma in 70.85% of cases and papilloma in 19.43%. The overall removal rate was 99.2%, and the upgrade rate was <1%. Fibroadenoma was significantly more common in younger people, had a larger width, and was located farther away from the nipple than papilloma. Individuals with a lesion size of 13.5 mm or less and an age of 36.5 years or older were more likely to have papilloma than fibroadenoma. The reported issues consisted of temporary localised discomfort and haematoma. There were no serious complications, no hospitalisation or operation as a result of a complication, and no infection or antibiotic use was reported.
VAE is a safe and effective alternative to open surgery for those with benign breast lesions. VAE can be utilised for both diagnostic and therapeutic purposes, making it a more cost-effective choice while also increasing patient satisfaction.
很大一部分女性害怕进行良性乳腺病变手术，这对医疗系统来说是一项负担。超声引导下真空辅助切除术（VAE）与手术效果相同，但无需全身麻醉，不留疤痕，且能提高患者满意度。
对一位乳腺外科医生记录的数据进行前瞻性队列研究的回顾性分析。使用EnCor Enspire设备和7G探头对611例ACR BIRADS 3或4a级病变患者进行VAE。平均随访时间为30.25±9.12个月。
共对平均直径为18.81±8.63毫米的病变进行了772次VAE。病理结果显示，70.85%的病例为纤维腺瘤，19.43%为乳头状瘤。总体切除率为99.2%，升级率<1%。纤维腺瘤在年轻人中更为常见，宽度更大，且比乳头状瘤距离乳头更远。病变大小为13.5毫米或更小且年龄在36.5岁或以上的个体比纤维腺瘤更易患乳头状瘤。报告的问题包括暂时性局部不适和血肿。未出现严重并发症，没有因并发症而住院或再次手术，也未报告感染或使用抗生素的情况。
对于患有良性乳腺病变的患者，VAE是一种安全有效的开放手术替代方案。VAE可用于诊断和治疗目的，使其成为更具成本效益的选择，同时还能提高患者满意度。
